Pfizer Says Two Cancer Drugs Fail in Clinical Trials (Update2)
March 11 (Bloomberg) — Pfizer Inc . said the cancer drug Sutent failed to halt the progression of advanced breast tumors in two studies, and the company stopped a trial of an experimental medicine to treat lung malignancy.

Read more on Bloomberg